FDA Approves Moderna's First mRNA Flu Vaccine for Older Adults
The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based influenza vaccine, Fluarix, marking the first mRNA flu vaccine to receive authorization. This new vaccine is specifically designed for use in adults aged 65 and older.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (96/100)Sources
F.D.A. Approves Moderna’s mRNA Flu Vaccine
The agency had initially refused to even review the application but reversed course after a public outcry.
By Christina Jewett
Read full article →A new flu vaccine geared to older people is coming soon
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
By Rob Stein
Read full article →FDA Approves First MRNA Flu Vaccine For Older Adults
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
By Siladitya Ray, Forbes Staff
Read full article →Moderna's mRNA Flu Vaccine Approved By FDA
Moderna's mRNA Flu Vaccine Approved By FDA Authored by Rachel Roberts via The Epoch Times, The U.S. Food and Drug Administration has approved Moderna's flu shot for over-50s, marking the first time the agency has licensed a messenger ribonucleic acid (mRNA) vaccine for seasonal influenza. Moderna bivalent COVID-19 vaccine at a clinic, in Richmond, Va., on November 17, 2022. AP Photo/Steve Helber, File The shot, known as mFlusiva, was given a traditional approval for adults ag...
By Tyler Durden
Read full article →
